Literature DB >> 11095704

Enzyme mimicry by the antiidiotypic antibody approach.

A V Kolesnikov1, A V Kozyr, E S Alexandrova, F Koralewski, A V Demin, M I Titov, B Avalle, A Tramontano, S Paul, D Thomas, A G Gabibov, A Friboulet.   

Abstract

The concept of "internal image" of antiidiotypic antibodies has provided the basis for eliciting catalytic antibodies. A monoclonal IgM 9A8 that was obtained as an antiidiotype to AE-2 mAb, a known inhibitor of acetylcholinesterase, displayed esterolytic activity. Study of recombinant Fab fragments and separate light and heavy chains of 9A8 confirmed that the antibody variable domain encodes the catalytic function, whereas neither part of the primary sequence of the Fab exhibited homology with the enzyme. The specific modification of the 9A8 variable domain by an active site-directed covalent inhibitor revealed the presence of an active site Ser residue. A three-dimensional modeling suggests the existence of a functional catalytic dyad Ser-His. Comparison of active sites of 9A8 and 17E8 esterolytic abzyme raised against transition-state analog revealed structural similarity although both antibodies were elicited by two different approaches.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11095704      PMCID: PMC17609          DOI: 10.1073/pnas.200360497

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Detection of receptor-ligand interactions using surface plasmon resonance: model studies employing the HIV-1 gp120/CD4 interaction.

Authors:  M Brigham-Burke; J R Edwards; D J O'Shannessy
Journal:  Anal Biochem       Date:  1992-08-15       Impact factor: 3.365

2.  Cleavage of vasoactive intestinal peptide at multiple sites by autoantibodies.

Authors:  S Paul; S Mei; B Mody; S H Eklund; C M Beach; R J Massey; F Hamel
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

3.  Inhibition and labeling of enzymes and abzymes by phosphonate diesters.

Authors:  A Tramontano; B Ivanov; G Gololobov; S Paul
Journal:  Appl Biochem Biotechnol       Date:  2000 Jan-Mar       Impact factor: 2.926

4.  [Topoisomerase I from human placenta. Functional activity of products of expression of cloned cDNA fragments].

Authors:  I B Bronshteĭn; A M Shuster; L V Shevchenko; I I Gromova; O A Kvashuk; O N Geva; A G Gabinov
Journal:  Mol Biol (Mosk)       Date:  1989 Nov-Dec

5.  DNA hydrolyzing autoantibodies.

Authors:  A M Shuster; G V Gololobov; O A Kvashuk; A E Bogomolova; I V Smirnov; A G Gabibov
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

6.  Catalytic antibodies.

Authors:  A Tramontano; K D Janda; R A Lerner
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

7.  Selective chemical catalysis by an antibody.

Authors:  S J Pollack; J W Jacobs; P G Schultz
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

8.  Detection of a catalytic antibody species acylated at the active site by electrospray mass spectrometry.

Authors:  J F Krebs; G Siuzdak; H J Dyson; J D Stewart; S J Benkovic
Journal:  Biochemistry       Date:  1995-01-24       Impact factor: 3.162

Review 9.  Excavations into the active-site gorge of cholinesterases.

Authors:  H Soreq; A Gnatt; Y Loewenstein; L F Neville
Journal:  Trends Biochem Sci       Date:  1992-09       Impact factor: 13.807

10.  Secretion and in vivo folding of the Fab fragment of the antibody McPC603 in Escherichia coli: influence of disulphides and cis-prolines.

Authors:  A Skerra; A Plückthun
Journal:  Protein Eng       Date:  1991-12
View more
  17 in total

1.  Functional mapping of the anti-idiotypic antibody anti-TS1 scFv using site-directed mutagenesis and kinetic analysis.

Authors:  Ann Erlandsson; Patrik Holm; Rozbeh Jafari; Torgny Stigbrand; Birgitta E Sundström
Journal:  MAbs       Date:  2010 Nov-Dec       Impact factor: 5.857

2.  The antiidiotypic approach to obtaining a proteolytic antibody.

Authors:  I V Smirnov; I I Vorobiev; A Friboulet; B Avalle; D Thomas; V D Knorre; A G Gabibov; N A Ponomarenko
Journal:  Dokl Biochem Biophys       Date:  2008 May-Jun       Impact factor: 0.788

3.  Chemical polysialylation of human recombinant butyrylcholinesterase delivers a long-acting bioscavenger for nerve agents in vivo.

Authors:  Denis G Ilyushin; Ivan V Smirnov; Alexey A Belogurov; Igor A Dyachenko; Tatiana Iu Zharmukhamedova; Tatjana I Novozhilova; Eugene A Bychikhin; Marina V Serebryakova; Oleg N Kharybin; Arkadii N Murashev; Konstantin A Anikienko; Eugene N Nikolaev; Natalia A Ponomarenko; Dmitry D Genkin; G Michael Blackburn; Patrick Masson; Alexander G Gabibov
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

4.  Deoxyribonuclease activity of polyclonal IgGs: a putative serological marker in patients with spondyloarthritides.

Authors:  Alena V Kundzer; Margarita V Volkova; Dimitrios P Bogdanos; Stefan Rödiger; Peter Schierack; I Generalov; Georgy A Nevinsky; Dirk Roggenbuck
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 5.  Catalytic antibodies in healthy humans and patients with autoimmune and viral diseases.

Authors:  G A Nevinsky; Valentina N Buneva
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

6.  Anti-idiotypic antibodies: a new approach in prion research.

Authors:  Anja Colja Venturini; Maja Bresjanac; Tanja Vranac; Simon Koren; Mojca Narat; Mara Popović; Vladka Curin Serbec
Journal:  BMC Immunol       Date:  2009-03-19       Impact factor: 3.615

7.  Human milk IgGs contain various combinations of different antigen-binding sites resulting in multiple variants of their bispecificity.

Authors:  Sergey E Sedykh; Valentina N Buneva; Georgy A Nevinsky
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

8.  Human milk sIgA molecules contain various combinations of different antigen-binding sites resulting in a multiple binding specificity of antibodies and enzymatic activities of abzymes.

Authors:  Sergey E Sedykh; Valentina N Buneva; Georgy A Nevinsky
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

9.  DNA-hydrolysing activity of IgG antibodies from the sera of patients with schizophrenia.

Authors:  Evgeny A Ermakov; Ludmila P Smirnova; Taisiya A Parkhomenko; Pavel S Dmitrenok; Nina M Krotenko; Nikolai S Fattakhov; Nikolay A Bokhan; Arkadiy V Semke; Svetlana A Ivanova; Valentina N Buneva; Georgy A Nevinsky
Journal:  Open Biol       Date:  2015-09       Impact factor: 6.411

10.  Biochemical features of a catalytic antibody light chain, 22F6, prepared from human lymphocytes.

Authors:  Emi Hifumi; Naoko Fujimoto; Mitsue Arakawa; Eri Saito; Shingo Matsumoto; Nobuyuki Kobayashi; Taizo Uda
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.